COMMUNIQUÉS West-GlobeNewswire

AIT Therapeutics Announces Year End 2017 Financial Results Conference Call and Webcast
13/03/2018
Call Scheduled for Monday, March 19, 2018 at 4:30pm Eastern Time. NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled [...]
Annual General Meeting 2018 – GN Store Nord A/S
13/03/2018
Today, GN Store Nord A/S held its annual general meeting in accordance with the agenda announced on February 19, 2018. The report by the board of directors was adopted, and both the Annual Report 2017 and the proposal [...]
Checkpoint Therapeutics to Participate in March Investor Conferences
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Mustang Bio to Present at March Investor Conferences
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
Fortress Biotech to Present at Oppenheimer’s 28th Annual Healthcare Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Fluidigm Announces Exchange of Convertible Notes
13/03/2018
SOUTH SAN FRANCISCO, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that it has entered into separate privately negotiated transactions to exchange approximately $25.0 [...]
Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer
13/03/2018
Dr. Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals, where as President and Chief Medical Officer, she oversaw the development of Viberzi [...]
OpGen Announces Collaborator in Verification Study for Acuitas® Test
13/03/2018
GAITHERSBURG, Md., March 13, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that it is collaborating with Beth Israel Deaconess Medical Center (BIDMC) in Boston on a verification study for OpGen’s [...]
Intra-Cellular Therapies Announces Positive Pre-NDA Meeting with FDA for Lumateperone for the Treatment of Schizophrenia
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones
13/03/2018
First Tazemetostat NDA Submission for Epithelioid Sarcoma Targeted for Fourth Quarter of 2018; Second Tazemetostat NDA Submission for Follicular Lymphoma Targeted for 2019 Multiple Phase 2 Study Data Readouts Planned in [...]
Pacific Biosciences Announces Issuance of U.S. Patent for Concatemer Sequencing
13/03/2018
MENLO PARK, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark [...]
Actinium Announces FDA Clearance of IND For Phase 1 trial of Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AML
13/03/2018
Clinical trial to be conducted by the Medical College of Wisconsin as an investigator initiated trial led by Dr. Sameem Abedin in collaboration with Dr. Ehab Atallah Combination trial expands addressable patient [...]
Summit's Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea
13/03/2018
Summit Therapeutics plc ("Summit" or the "Company") Summit's Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea Oxford, UK, and Cambridge, MA, US, 13 March [...]
Sunesis Pharmaceuticals Announces Cancellation of Presentation and Webcast at Cowen & Company 38th Annual Health Care Conference
13/03/2018
Cancellation due to Travel Changes Caused by Inclement Weather Management to Proceed with Scheduled Investor Meetings via Conference Calls SOUTH SAN FRANCISCO, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Sunesis [...]
Tonix Pharmaceuticals to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), announced today that it will present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering [...]
Melinta Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
13/03/2018
Baxdela ™ (delafloxacin) Launched February 6, 2018, in U.S. for Adults with ABSSSI Acquired Infectious Disease Business from The Medicines Company on January 5, 2018 First Earnings Report as a Public Company NEW HAVEN, [...]
Affimed Announces Fourth Quarter and Year End 2017 Financial Results and Corporate Update Conference Call
13/03/2018
Heidelberg, Germany, March 13, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that on March [...]
PotNetwork Holding To Enter World’s Fastest Growing Market With Formation Of Blockchain Crypto Technology Subsidiary
13/03/2018
FT LAUDERDALE, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding Inc. (OTC Pink:POTN) (“Company”), announced today that after considerable evaluation and planning, the Company enters into [...]
Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration
13/03/2018
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated development of MultiStem [...]

Pages